XLO Xilio Therapeutics, Inc.
Price Chart
Executive Summary
Xilio Therapeutics' S-3 shelf registration (File No. 333-295785) became effective on May 29, 2026, allowing the company to offer up to $250M in securities including a $17.22M ATM facility with Leerink Partners. This gives Xilio immediate access to equity capital markets, creating potential dilution overhang for existing shareholders.
Actionable Insight
Monitor for prospectus supplements indicating actual takedowns under the shelf or ATM. Any announced offering of size >$5M would likely pressure XLO shares given the small market cap. Watch for accelerated shelf filings or overnight offerings.
Key Facts
- Shelf registration effective May 29, 2026 under File No. 333-295785
- Up to $250M in securities registered (common, preferred, debt, units, warrants)
- Includes $17.22M ATM facility with Leerink Partners
- Company has $56M market cap — potential dilution is significant relative to current equity value
- Prior S-3/A (filed May 27) noted $72.5M net tangible book value as of March 31, 2026
Financial Impact
Up to $250M in securities can be sold; $17.22M ATM facility represents ~31% of current $56M market cap
Risk Factors
- Immediate dilution risk if company draws on ATM or conducts follow-on offering
- Shelf overhang may cap upside until clarity on capital needs emerges
- Biotech sector capital market conditions could influence timing and size of offerings
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001811 |
| Document: 9999999995-26-001811-index.html | 9999999995-26-001811 |
| Document: 9999999995-26-001811.txt | 9999999995-26-001811 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
12d ago
|
EFFECT
| $8.25 $7.70 | ▲ +6.67% | ▲ +3.92% | $8.31 (−0.73%) |
|
May 27, 2026
16d ago
|
S-3/A
| $8.52 $8.15 | ▼ −4.40% | ▼ −4.35% | $8.31 (−2.46%) |
|
May 12, 2026
4w ago
|
8-K
| $7.73 $8.15 | ▲ +5.43% | ▲ +5.36% | $8.31 (+7.50%) |
|
May 12, 2026
4w ago
|
Press Release
| $7.73 $8.15 | ▲ +5.43% | ▲ +5.36% | $8.31 (+7.50%) |
|
Apr 17, 2026
8w ago
|
Press Release
| $8.45 $8.18 | ▼ −3.20% | ▼ −4.11% | $8.31 (−1.66%) |
|
Apr 16, 2026
8w ago
|
3
| $8.57 $8.31 | ▼ −3.03% | ▼ −3.59% | $8.31 (−3.03%) |
|
Apr 16, 2026
8w ago
|
8-K
| $8.35 $8.47 | ▲ +1.44% | ▲ +0.45% | $8.31 (−0.48%) |
|
Mar 23, 2026
11w ago
|
Press Release
| $7.86 $8.24 | ▲ +4.77% | ▲ +8.34% | $8.31 (+5.73%) |
|
Mar 17, 2026
12w ago
|
Press Release
| $7.60 $8.53 | ▲ +12.24% | ▲ +12.95% | $8.31 (+9.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access